However, another study showed only a marginal difference between dMMR (67% negative) and pMMR (58%) colorectal carcinomas [52] while three further studies found no difference in CEA immunostaining between dMMR and pMMR carcinomas [53,54,55]. This evidence concerns the gene CEACAM5 and colorectal carcinoma.